Global (United States, European Union and China) Biosimilar Market Research Report 2019-2025

Publisher Name :
Date: 14-Aug-2019
No. of pages: 117
Inquire Before Buying

A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.

In 2019, the market size of Biosimilar is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 25.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biosimilar.

This report studies the global market size of Biosimilar, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Biosimilar sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Allergan plc

- BIOCAD

- Biocon

- BioXpress Therapeutics

- Boehringer Ingelheim

- Celltrion

- Coherus BioSciences

- Dr. Reddy's Laboratories

- Genor BioPharma

- Intas Pharmaceuticals Limited

- Novartis

- Pfizer

- Reliance Life Sciences

Market Segment by Product Type

- Human Growth Hormones

- Monoclonal Antibodies

- Insulin

- Peptides

- Erythropoietin

- Others

Market Segment by Application

- Oncology

- Chronic and Autoimmune Diseases

- Growth Hormone Deficiency

- Infectious Diseases

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Biosimilar status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Biosimilar manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biosimilar are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Biosimilar Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biosimilar Market Size Growth Rate by Type (2019-2025)
1.3.2 Human Growth Hormones
1.3.3 Monoclonal Antibodies
1.3.4 Insulin
1.3.5 Peptides
1.3.6 Erythropoietin
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Biosimilar Market Share by Application (2019-2025)
1.4.2 Oncology
1.4.3 Chronic and Autoimmune Diseases
1.4.4 Growth Hormone Deficiency
1.4.5 Infectious Diseases
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Market Size
2.1.1 Global Biosimilar Revenue 2014-2025
2.1.2 Global Biosimilar Sales 2014-2025
2.2 Biosimilar Growth Rate by Regions
2.2.1 Global Biosimilar Sales by Regions 2014-2019
2.2.2 Global Biosimilar Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biosimilar Sales by Manufacturers
3.1.1 Biosimilar Sales by Manufacturers 2014-2019
3.1.2 Biosimilar Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Biosimilar Revenue by Manufacturers (2014-2019)
3.2.2 Biosimilar Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI)
3.3 Biosimilar Price by Manufacturers
3.4 Key Manufacturers Biosimilar Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biosimilar Market
3.6 Key Manufacturers Biosimilar Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Human Growth Hormones Sales and Revenue (2014-2019)
4.1.2 Monoclonal Antibodies Sales and Revenue (2014-2019)
4.1.3 Insulin Sales and Revenue (2014-2019)
4.1.4 Peptides Sales and Revenue (2014-2019)
4.1.5 Erythropoietin Sales and Revenue (2014-2019)
4.1.6 Others Sales and Revenue (2014-2019)
4.2 Global Biosimilar Sales Market Share by Type
4.3 Global Biosimilar Revenue Market Share by Type
4.4 Biosimilar Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biosimilar Sales by Application
6 United States
6.1 United States Biosimilar Breakdown Data by Company
6.2 United States Biosimilar Breakdown Data by Type
6.3 United States Biosimilar Breakdown Data by Application
7 European Union
7.1 European Union Biosimilar Breakdown Data by Company
7.2 European Union Biosimilar Breakdown Data by Type
7.3 European Union Biosimilar Breakdown Data by Application
8 China
8.1 China Biosimilar Breakdown Data by Company
8.2 China Biosimilar Breakdown Data by Type
8.3 China Biosimilar Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biosimilar Breakdown Data by Company
9.2 Rest of World Biosimilar Breakdown Data by Type
9.3 Rest of World Biosimilar Breakdown Data by Application
9.4 Rest of World Biosimilar Breakdown Data by Countries
9.4.1 Rest of World Biosimilar Sales by Countries
9.4.2 Rest of World Biosimilar Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Allergan plc
10.1.1 Allergan plc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biosimilar
10.1.4 Biosimilar Product Introduction
10.1.5 Allergan plc Recent Development
10.2 BIOCAD
10.2.1 BIOCAD Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biosimilar
10.2.4 Biosimilar Product Introduction
10.2.5 BIOCAD Recent Development
10.3 Biocon
10.3.1 Biocon Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biosimilar
10.3.4 Biosimilar Product Introduction
10.3.5 Biocon Recent Development
10.4 BioXpress Therapeutics
10.4.1 BioXpress Therapeutics Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biosimilar
10.4.4 Biosimilar Product Introduction
10.4.5 BioXpress Therapeutics Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biosimilar
10.5.4 Biosimilar Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Celltrion
10.6.1 Celltrion Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biosimilar
10.6.4 Biosimilar Product Introduction
10.6.5 Celltrion Recent Development
10.7 Coherus BioSciences
10.7.1 Coherus BioSciences Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biosimilar
10.7.4 Biosimilar Product Introduction
10.7.5 Coherus BioSciences Recent Development
10.8 Dr. Reddy's Laboratories
10.8.1 Dr. Reddy's Laboratories Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biosimilar
10.8.4 Biosimilar Product Introduction
10.8.5 Dr. Reddy's Laboratories Recent Development
10.9 Genor BioPharma
10.9.1 Genor BioPharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biosimilar
10.9.4 Biosimilar Product Introduction
10.9.5 Genor BioPharma Recent Development
10.10 Intas Pharmaceuticals Limited
10.10.1 Intas Pharmaceuticals Limited Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Biosimilar
10.10.4 Biosimilar Product Introduction
10.10.5 Intas Pharmaceuticals Limited Recent Development
10.11 Novartis
10.12 Pfizer
10.13 Reliance Life Sciences
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biosimilar Sales Channels
11.2.2 Biosimilar Distributors
11.3 Biosimilar Customers
12 Market Forecast
12.1 Global Biosimilar Sales and Revenue Forecast 2019-2025
12.2 Global Biosimilar Sales Forecast by Type
12.3 Global Biosimilar Sales Forecast by Application
12.4 Biosimilar Forecast by Regions
12.4.1 Global Biosimilar Sales Forecast by Regions 2019-2025
12.4.2 Global Biosimilar Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Biosimilar Product Picture
Table Biosimilar Key Market Segments
Table Major Manufacturers Biosimilar Covered in This Report
Table Global Biosimilar Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Biosimilar Sales Market Shar by Type 2014-2025
Figure Human Growth Hormones Figures
Table Major Manufacturers of Human Growth Hormones
Figure Monoclonal Antibodies Figures
Table Major Manufacturers of Monoclonal Antibodies
Figure Insulin Figures
Table Major Manufacturers of Insulin
Figure Peptides Figures
Table Major Manufacturers of Peptides
Figure Erythropoietin Figures
Table Major Manufacturers of Erythropoietin
Figure Others Figures
Table Major Manufacturers of Others
Table Global Biosimilar Market Share by Application 2019-2025 (K Units)
Figure Oncology Use Case
Figure Chronic and Autoimmune Diseases Use Case
Figure Growth Hormone Deficiency Use Case
Figure Infectious Diseases Use Case
Figure Others Use Case
Figure Biosimilar Report Years Considered
Figure Global Biosimilar Market Size 2014-2025 (Million US$)
Figure Global Biosimilar Sales 2014-2019 (K Units)
Table Global Biosimilar Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biosimilar Sales by Regions 2014-2019 (K Units)
Table Global Biosimilar Sales Market Share by Regions 2014-2019
Figure Global Biosimilar Sales Market Share by Regions 2014-2019
Figure Global Biosimilar Sales Market Share by Regions in 2019
Table Global Biosimilar Revenue by Regions 2014-2019 (Million US$)
Table Global Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Biosimilar Sales by Manufacturers (2014-2019) (K Units)
Table Global Biosimilar Sales Share by Manufacturers (2014-2019)
Figure Global Biosimilar Sales Share by Manufacturers in 2019
Table Biosimilar Revenue by Manufacturers (2014-2019) (Million USD)
Table Biosimilar Revenue Share by Manufacturers (2014-2019)
Figure Biosimilar Value Share by Manufacturers in 2019
Table Global Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biosimilar Price (2014-2019) (USD/Unit)
Table Key Manufacturers Biosimilar Plants/Factories Distribution
Table Key Manufacturers Biosimilar Area Served
Table Date of Key Manufacturers Enter into Biosimilar Market
Table Key Manufacturers Biosimilar Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Growth Hormones Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Monoclonal Antibodies Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Insulin Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Peptides Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Erythropoietin Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Others Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Biosimilar Sales by Type (2014-2019) (K Units)
Table Global Biosimilar Sales Share by Type (2014-2019)
Figure Global Biosimilar Sales Market Share by Type (2014-2019)
Figure Global Biosimilar Sales Market Share by Type in 2018
Table Global Biosimilar Revenue by Type (2014-2019) (Million US$)
Table Global Biosimilar Revenue Share by Type (2014-2019)
Figure Global Biosimilar Revenue Market Share by Type (2014-2019)
Figure Global Biosimilar Revenue Market Share by Type in 2018
Table Biosimilar Price by Type 2014-2019 (USD/Unit)
Table Global Biosimilar Sales by Application (2014-2019) (K Units)
Table Global Biosimilar Sales Share by Application (2014-2019)
Figure Global Sales Biosimilar Market Share by Application (2014-2019)
Figure Global Sales Biosimilar Market Share by Application (2014-2019)
Figure United States Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure United States Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table United States Biosimilar Sales by Company (2014-2019) (K Units)
Table United States Biosimilar Sales Market Share by Company (2014-2019)
Figure United States Biosimilar Sales Market Share by Company in 2019
Table United States Biosimilar Sales by Type (2014-2019) (K Units)
Table United States Biosimilar Sales Market Share by Type (2014-2019)
Figure United States Biosimilar Market Share by Type in 2019
Table United States Biosimilar Sales by Application (2014-2019) (K Units)
Table United States Biosimilar Sales Market Share by Application (2014-2019)
Figure United States Biosimilar Market Share by Application in 2019
Figure European Union Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure European Union Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Biosimilar Sales by Company (2014-2019) (K Units)
Table European Union Biosimilar Sales Market Share by Company (2014-2019)
Figure European Union Biosimilar Sales Market Share by Company in 2019
Table European Union Biosimilar Sales by Type (2014-2019) (K Units)
Table European Union Biosimilar Sales Market Share by Type (2014-2019)
Figure 2018 European Union Biosimilar Market Share by Type
Table European Union Biosimilar Sales by Application (2014-2019) (K Units)
Table European Union Biosimilar Sales Market Share by Application (2014-2019)
Figure 2018 European Union Biosimilar Market Share by Application
Figure China Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure China Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table China Biosimilar Sales by Company (2014-2019) (K Units)
Table China Biosimilar Sales Market Share by Company (2014-2019)
Figure China Biosimilar Sales Market Share by Company in 2019
Table China Biosimilar Sales by Type (2014-2019) (K Units)
Table China Biosimilar Sales Market Share by Type (2014-2019)
Figure China Biosimilar Market Share by Type in 2019
Table China Biosimilar Sales by Application (2014-2019) (K Units)
Table China Biosimilar Sales Market Share by Application (2014-2019)
Figure China Biosimilar Market Share by Application in 2019
Figure Rest of World Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Biosimilar Sales by Company (2014-2019) (K Units)
Table Rest of World Biosimilar Sales Market Share by Company (2014-2019)
Figure Rest of World Biosimilar Sales Market Share by Company in 2019
Table Rest of World Biosimilar Sales by Type (2014-2019) (K Units)
Table Rest of World Biosimilar Sales Market Share by Type (2014-2019)
Figure Rest of World Biosimilar Market Share by Type in 2019
Table Rest of World Biosimilar Sales by Application (2014-2019) (K Units)
Table Rest of World Biosimilar Sales Market Share by Application (2014-2019)
Figure Rest of World Biosimilar Market Share by Application in 2019
Table Rest of World Biosimilar Sales by Countries (2014-2019) (K Units)
Table Rest of World Biosimilar Sales Market Share by Countries (2014-2019)
Figure Rest of World Biosimilar Sales Market Share by Countries in 2019
Table Rest of World Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Biosimilar Revenue Market Share by Countries (2014-2019)
Figure Rest of World Biosimilar Revenue Market Share by Countries in 2019
Figure Japan Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Figure India Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure India Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Table Allergan plc Company Details
Table Allergan plc Description and Business Overview
Table Allergan plc Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan plc Biosimilar Sales Growth Rate (2014-2019)
Table Allergan plc Biosimilar Sales Market Share in Global Market
Table Allergan plc Recent Development
Table BIOCAD Company Details
Table BIOCAD Description and Business Overview
Table BIOCAD Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOCAD Biosimilar Sales Growth Rate (2014-2019)
Table BIOCAD Biosimilar Sales Market Share in Global Market
Table BIOCAD Recent Development
Table Biocon Company Details
Table Biocon Description and Business Overview
Table Biocon Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Biosimilar Sales Growth Rate (2014-2019)
Table Biocon Biosimilar Sales Market Share in Global Market
Table Biocon Recent Development
Table BioXpress Therapeutics Company Details
Table BioXpress Therapeutics Description and Business Overview
Table BioXpress Therapeutics Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioXpress Therapeutics Biosimilar Sales Growth Rate (2014-2019)
Table BioXpress Therapeutics Biosimilar Sales Market Share in Global Market
Table BioXpress Therapeutics Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Biosimilar Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Biosimilar Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Celltrion Company Details
Table Celltrion Description and Business Overview
Table Celltrion Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Biosimilar Sales Growth Rate (2014-2019)
Table Celltrion Biosimilar Sales Market Share in Global Market
Table Celltrion Recent Development
Table Coherus BioSciences Company Details
Table Coherus BioSciences Description and Business Overview
Table Coherus BioSciences Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Coherus BioSciences Biosimilar Sales Growth Rate (2014-2019)
Table Coherus BioSciences Biosimilar Sales Market Share in Global Market
Table Coherus BioSciences Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Description and Business Overview
Table Dr. Reddy's Laboratories Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Biosimilar Sales Growth Rate (2014-2019)
Table Dr. Reddy's Laboratories Biosimilar Sales Market Share in Global Market
Table Dr. Reddy's Laboratories Recent Development
Table Genor BioPharma Company Details
Table Genor BioPharma Description and Business Overview
Table Genor BioPharma Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genor BioPharma Biosimilar Sales Growth Rate (2014-2019)
Table Genor BioPharma Biosimilar Sales Market Share in Global Market
Table Genor BioPharma Recent Development
Table Intas Pharmaceuticals Limited Company Details
Table Intas Pharmaceuticals Limited Description and Business Overview
Table Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intas Pharmaceuticals Limited Biosimilar Sales Growth Rate (2014-2019)
Table Intas Pharmaceuticals Limited Biosimilar Sales Market Share in Global Market
Table Intas Pharmaceuticals Limited Recent Development
Table Novartis Company Details
Table Pfizer Company Details
Table Reliance Life Sciences Company Details
Figure Biosimilar Value Chain
Table Biosimilar Distributors List
Table Biosimilar Customers List
Table Global Biosimilar Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Biosimilar Sales Forecast 2019-2025 (K Units)
Figure Global Biosimilar Revenue Forecast 2019-2025 (Million US$)
Table Global Biosimilar Sales Forecast by Type 2019-2025 (K Units)
Figure Global Biosimilar Sales Forecast by Type 2019-2025 (K Units)
Figure Global Biosimilar Sales Market Share Forecast by Type 2019-2025
Table Global Biosimilar Sales Forecast by Application 2019-2025 (K Units)
Figure Global Biosimilar Sales Forecast by Application 2019-2025 (K Units)
Figure Global Biosimilar Sales Market Share Forecast by Application 2019-2025
Table Global Biosimilar Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Biosimilar Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Biosimilar Sales Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Biosimilar Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Biosimilar Revenue Market Share Forecast by Regions 2019-2025
Figure United States Biosimilar Sales Forecast 2019-2025 (K Units)
Figure United States Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure European Union Biosimilar Sales Forecast 2019-2025 (K Units)
Figure European Union Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure China Biosimilar Sales Forecast 2019-2025 (K Units)
Figure China Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure Japan Biosimilar Sales Forecast 2019-2025 (K Units)
Figure Japan Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure Korea Biosimilar Sales Forecast 2019-2025 (K Units)
Figure Korea Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure India Biosimilar Sales Forecast 2019-2025 (K Units)
Figure India Biosimilar Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Biosimilar Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Biosimilar Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs